Elanco Animal Health
ELAN
351 hedge funds and large institutions have $4.76B invested in Elanco Animal Health in 2023 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 133 increasing their positions, 113 reducing their positions, and 91 closing their positions.
58% more call options, than puts
Call options by funds: $26.4M | Put options by funds: $16.7M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
18% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 113
6% more capital invested
Capital invested by funds: $4.51B → $4.76B (+$257M)
1.14% less ownership
Funds ownership: 97.32% → 96.18% (-1.1%)
10% less funds holding
Funds holding: 388 → 351 (-37)
38% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 91
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$89.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$65.6M |
| 3 |
Primecap Management
Pasadena,
California
|
+$48.2M |
| 4 |
Holocene Advisors
New York
|
+$46.1M |
| 5 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$32.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
-$125M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$60.5M |
| 3 |
JP Morgan Chase
New York
|
-$57M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$42.8M |
| 5 |
Renaissance Technologies
New York
|
-$31.5M |
ELAN Hedge Fund Activity: Q2 2023 in Review
351 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2023, worth a combined $4.76B — up 5.7% from $4.51B a quarter earlier.
Sellers outnumbered buyers: 91 funds closed out of ELAN and 56 opened new positions — a net loss of 35 holders — while 113 trimmed existing stakes and 133 added.
The largest buyer was Citadel Advisors, adding an estimated $89.1M. The largest seller was Amundi, cutting an estimated $125M.
- 351 institutional investors held Elanco Animal Health (ELAN) as of Q2 2023, down from 388 in Q1 2023.
- Funds reported $4.76B of Elanco Animal Health stock for Q2 2023, up 5.7% quarter-over-quarter.
- 56 funds opened new Elanco Animal Health positions in Q2 2023 and 91 closed out, a net change of -35 holders.
- The largest Elanco Animal Health buyer in Q2 2023 was Citadel Advisors, an estimated $89.1M added.
- The largest Elanco Animal Health seller in Q2 2023 was Amundi, an estimated $125M sold.
Based on aggregated 13F filings for Q2 2023.